StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
Huagongshe Open Project:[email protected]KI-Anbindung: llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.7.8
  1. Startseite
  2. /Verbindung

Pridinol

HCID 4904
NotizenReaktionen
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
511-45-5
Standard-SMILES
OC(CCN1CCCCC1)(c1ccccc1)c1ccccc1
InChIKey
RQXCLMGKHJWMOA-UHFFFAOYSA-N
Summenformel
C20H25NO
Durchschnittliche Molmasse
295,4 g/mol
Monoisotopische Masse
295,19361442

Überblick

Pridinol is a piperidine substituted at position 1 by a 3-hydroxy-3,3-diphenylpropyl group. It has a role as an antiparkinson drug and a muscle relaxant. It is a member of piperidines and a tertiary alcohol.

Namen und Bezeichner

Bevorzugter Name
Pridinol
IUPAC
1,1-diphenyl-3-piperidin-1-ylpropan-1-ol
Lokaler Name
Pridinol
Englischer Name
pridinol
Summenformel
C20H25NO
Molmasse
295.4186

Namen und Synonyme

pridinol511-45-51,1-diphenyl-3-(piperidin-1-yl)propan-1-olNonplesinParksParks 12 hommelPridinolumRidinolParks 121,1-Diphenyl-3-(1-piperidyl)-1-propanolC-238HH 212
Weitere Namen anzeigen
HH-212Diphepanol1-Piperidinepropanol, α,α-diphenyl-α,α-Diphenyl-1-piperidine-1-propanol
1-Piperidinepropanol, alpha,alpha-diphenyl-3-(N-Piperidyl)-1,1-diphenyl-1-propanol1,1-Diphenyl-3-piperidino-1-propanolNSC-23016238 CDTXSID0045090alpha,alpha-Diphenyl-1-piperidinepropanol9E75Q6SUUB

Datenbank-Bezeichner

CAS
511-45-5
PubChem CID
4904
DTXSID
DTXSID0045090
ChEMBL
CHEMBL404215
ChEBI
CHEBI:75247
UNII
9E75Q6SUUB
EC Number
208-128-0
Nikkaji
J6.268E

Eigenschaften

Berechnete Struktureigenschaften

XLogP
3,8
Polarare Oberfläche (TPSA)
23,5 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
2
Frei drehbare Bindungen
5
Schwere Atome
22
Formalladung
0
Komplexität
294

Experimentelle und physikochemische Eigenschaften

DrugsPharmaceuticals
Color/FormCrystals
Solubility · 2 Einträge

MW: 391.52. Crystals, mp 152.5-155.0 °C. Sparingly sol in water /Methanesulfonate/

Soluble in acetone

Human DrugsPharmaceuticals
Melting Point120-121 °C
Other Experimental PropertiesMW: 331.88. Crystals, decomposes 238 °C. Soluble in alcohol. /Hydrochloride/

Physikochemische Eigenschaften

Schmelzpunkt
120 · 120-121°
Siedepunkt
460.9 · 460.9±45.0 °C(Predicted)
Dichte
1.079 · 1.079±0.06 g/cm3(Predicted)
pka
13.49 · 13.49±0.29(Predicted)

Sicherheit und Regulatorisches

Sicherheit und Schutzausrüstung

Disposal Methods · 1 Eintrag

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

Toxikologische Informationen

Antidote and Emergency Treatment · 3 Einträge

/SRP:/ Immediate first aid: Ensure that adequate decontamination has been carried out. If patient is not breathing, start artificial respiration, preferably with a demand valve resuscitator, bag-valve-mask device, or pocket mask, as trained. Perform CPR if necessary. Immediately flush contaminated eyes with gently flowing water. Do not induce vomiting. If vomiting occurs, lean patient forward or place on the left side (head-down position, if possible) to maintain an open airway and prevent aspiration. Keep patient quiet and maintain normal body temperature. Obtain medical attention. /Poisons A and B/

/SRP:/ Basic treatment: Establish a patent airway (oropharyngeal or nasopharyngeal airway, if needed). Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if needed. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for pulmonary edema and treat if necessary ... . Monitor for shock and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with 0.9% saline (NS) during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 mL/kg up to 200 mL of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool ... . Cover skin burns with dry sterile dressings after decontamination ... . /Poisons A and B/

/SRP:/ Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the patient who is unconscious, has severe pulmonary edema, or is in severe respiratory distress. Positive-pressure ventilation techniques with a bag valve mask device may be beneficial. Consider drug therapy for pulmonary edema ... . Consider administering a beta agonist such as albuterol for severe bronchospasm ... . Monitor cardiac rhythm and treat arrhythmias as necessary ... . Start IV administration of D5W /SRP: "To keep open", minimal flow rate/. Use 0.9% saline (NS) or lactated Ringer's if signs of hypovolemia are present. For hypotension with signs of hypovolemia, administer fluid cautiously. Watch for signs of fluid overload ... . Treat seizures with diazepam or lorazepam ... . Use proparacaine hydrochloride to assist eye irrigation ... . /Poisons A and B/

Non-Human Toxicity ValuesLD50 MOUSE INTRAVENOUS 35 MG/KG /PRIDINOL HYDROCHLORIDE/

Sicherheitsdaten

Toxizität
LD50 intraperitoneal in mouse: 100mg/kg
Giftige Stoffe Daten
511-45-5(Hazardous Substances Data)

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 2 Einträge

M - Musculo-skeletal system

QM - Musculo-skeletal system

Verwendung und Herstellung

Uses · 2 Einträge

THERAP CAT: Antiparkinsonian; muscle relaxant (skeletal)

Use (kg; approx.) in Germany (2009): >10

Methods of Manufacturing · 2 Einträge

Pridinol can be prepared by Grignard reaction of ethyl 3-piperidinopropionate with phenylmagnesium bromide.

May be prepared from ethyl 1-piperidinepropionate and phenylmagnesium bromide

Use ClassificationPharmaceuticals

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

1,3-Propanediol, 1,1-diphenyl-3-(1-Piperidinyl)propiophenone HClEthylpiperidin-1-propionatMethyl 3-(piperidin-1-yl)propanoatePiperidin1-(2-Chloroethyl)-piperidineBenzophenonBromphenylmagnesium

Anbieter25 Anbieter

LGM Pharma1-(800)-881-8210 · [email protected]
上海稳同科技有限公司02151600108 13062666369 · [email protected]
上海昶衍化工科技有限公司021-20242659 18930833303 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
韶远科技(上海)有限公司021-50795510 4000665055 · [email protected]
成都大道三灵生物科技有限公司18108108965 18108108965 · [email protected]
上海陶术生物科技股份有限公司13564774135 · [email protected]
南京博米尔生物科技有限公司025-83453382-8005 · [email protected]
上海林栎生物科技有限公司13761635123 · [email protected]
武汉弘德悦欣医药科技有限公司027-83850116 18164090116 · [email protected]
陕西爱施达尔生物科技有限公司18682931470; 18682931470 · [email protected]
江苏艾康生物医药研发有限公司025-58859352 19370895928 · [email protected]
武汉峰耀同辉化学制品有限公司027-87466105 15377573527 · [email protected]
临沂艾泽拉斯生物科技有限公司17753923223 · [email protected]
career henan chemical co+86-0371-86658258 · [email protected]
ATK CHEMICAL COMPANY LIMITED+undefined-21-51877795 · [email protected]
上海凯裕医药科技有限公司17317130613 · [email protected]
Accela ChemBio Inc.+1-858-6993322 +86-18019713315 · [email protected]
湖北玖天生物医药科技有限公司027-88013699 17354350817 · [email protected]
TargetMol中国(陶术生物)4008200310 15002144251 · [email protected]
Alchem Pharmtech,Inc.8485655694 · [email protected]
南京宁吉通医药生物科技有限公司0-19710401727 19710401727 · [email protected]
上海佰世凯生物科技有限公司021-20908456 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354 · [email protected]
梯尔希(南京)药物研发有限公司18012923235 · [email protected]

Ergänzende Hinweise

DefinitionChEBI: A piperidine substituted at position 1 by a 3-hydroxy-3,3-diphenylpropyl group.

Zugehörige Reaktionen

1
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 523861
HRID 523861als Eduktuspto-grants-2016_05

Notizen zur Verbindung

Wird geladen…

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung